Blom I E, van Dijk A J, Wieten L, Duran K, Ito Y, Kleij L, deNichilo M, Rabelink T J, Weening J J, Aten J, Goldschmeding R
Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Nephrol Dial Transplant. 2001 Jun;16(6):1139-48. doi: 10.1093/ndt/16.6.1139.
Connective tissue growth factor (CTGF) is a profibrotic growth factor, which is upregulated in wound healing and renal fibrosis, including anti-Thy-1.1 nephritis. The kinetics of CTGF mRNA expression in anti-Thy-1.1 nephritis suggested that CTGF regulation might contribute to glomerular response to injury downstream of transforming growth factor-beta (TGFbeta). In anti-Thy-1.1 nephritis the initial damage is followed by mesangial repair and limited sclerosis, which involves mesangial cell (MC) activation (alpha-smooth-muscle actin (alphaSMA) expression), proliferation, migration, and extracellular matrix production. The present in vitro study addresses the possible role of CTGF in these different aspects of mesangial response to injury, and how CTGF activity might relate to effects of TGFbeta and platelet-derived growth factor-BB (PDGF-BB).
Immunostaining and ELISA showed that alphaSMA expression and transformation of MC into myofibroblast-like cells was induced by TGFbeta, but not affected by PDGF-BB, CTGF, or neutralizing anti-CTGF antibodies. [(3)H]thymidine incorporation and Ki67 staining demonstrated that, unlike PDGF-BB, neither CTGF nor TGFbeta induced the proliferation of MC. In contrast, both CTGF and TGFbeta induced MC migration, as evidenced by approximation of wound edges in scrape-wounded, non-proliferating rat MC monolayers. In addition, fibronectin expression was upregulated by both CTGF and TGFbeta, as measured by dot-blot analysis. Anti-CTGF completely blocked the effect of added CTGF. Moreover, anti-CTGF significantly reduced TGFbeta-induced increase in fibronectin.
It thus appears that CTGF is specifically involved in a subset of the adaptive changes of MC involved in mesangial repair and sclerosis, which makes it an interesting candidate target for future intervention strategies.
结缔组织生长因子(CTGF)是一种促纤维化生长因子,在伤口愈合和肾纤维化(包括抗Thy-1.1肾炎)中表达上调。抗Thy-1.1肾炎中CTGF mRNA表达的动力学表明,CTGF的调节可能有助于肾小球对转化生长因子-β(TGFβ)下游损伤的反应。在抗Thy-1.1肾炎中,最初的损伤之后是系膜修复和有限的硬化,这涉及系膜细胞(MC)激活(α-平滑肌肌动蛋白(αSMA)表达)、增殖、迁移和细胞外基质产生。本体外研究探讨了CTGF在系膜对损伤的这些不同反应方面可能发挥的作用,以及CTGF活性与TGFβ和血小板衍生生长因子-BB(PDGF-BB)作用之间的关系。
免疫染色和ELISA显示,TGFβ可诱导αSMA表达以及MC向肌成纤维细胞样细胞的转化,但不受PDGF-BB、CTGF或中和性抗CTGF抗体的影响。[3H]胸腺嘧啶核苷掺入和Ki67染色表明,与PDGF-BB不同,CTGF和TGFβ均未诱导MC增殖。相反,CTGF和TGFβ均诱导MC迁移,刮伤、未增殖的大鼠MC单层伤口边缘接近可证明这一点。此外,通过斑点印迹分析测量,CTGF和TGFβ均上调了纤连蛋白表达。抗CTGF完全阻断了添加CTGF的作用。此外,抗CTGF显著降低了TGFβ诱导的纤连蛋白增加。
因此,CTGF似乎特别参与了系膜修复和硬化中MC适应性变化的一个子集,这使其成为未来干预策略中一个有趣的候选靶点。